Choose Category

Showing: 824 Reports
Checked Checkbox

Customization Available

Checked Checkbox

PDF, PPT, XLS

Price: $1,899 Onwards

Worldwide statistics indicate that there is a high cholesterol burden despite the presence of many cholesterol-lowering drugs in the market. Out of all the available options, statins have been ubiquitously prescribed over the last 25 years. Statins, though the mainstay therapy for lowering cholesterol, have been associated with some adverse events. These have deterred their use in a subset of population termed as

Checked Checkbox

Customization Available

Checked Checkbox

PDF, PPT, XLS

Price: $1,899 Onwards

Oral targeted therapeutics has attracted many drug developers due to the ease of administration it offers to patients (especially pediatric and geriatric patients). However, the high price of these drugs still remains a major constraint to the market growth. Further, as leukemia accounts for about 3% of all cancer cases per year, most of the companies are targeting other cancer indications offering a wider market prospective. Notably, there are specific opportunities which remain to be tapped in...

Checked Checkbox

Customization Available

Checked Checkbox

PDF, PPT, XLS

Price: $1,899 Onwards

With nearly 300 million dry eye sufferers worldwide, dry eye represents one of the largest ophthalmic indications. The prevalence of dry eye syndrome primarily increases with age, and has an estimated incidence of 15% in persons over the age of 65 years. In fact, tn the US alone, the economic burden of dry eye totals USD 3.84 billion in direct annual health care costs. After including the indirect costs of lost productivity, the societal burden of dry eye rises to USD 55.4 billion annually in t...

Checked Checkbox

Customization Available

Checked Checkbox

PDF, PPT, XLS

Price: $799 Onwards